Clinical Trial Update: Evaluation of Dose Response Relationship, Safety and Efficacy of GSK1278863 in Hemodialysis-dependent Subjects With Chronic Kidney Disease Associated Anemia [Phase 2]

View source ↗

Summary

Phase 2 dose‑response study evaluating the safety and efficacy of GSK1278863 (daprodustat) for anemia in hemodialysis-dependent patients with chronic kidney dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease

Drugs mentioned

• GSK1278863

Snippet

Sponsor: GlaxoSmithKline | Conditions: Anaemia | Phase 2 | Status: COMPLETED | Results posted: 2017-02-14